| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.24 | 8e-08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |